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Abstract Phosphoenolpyruvate carboxykinase (PEPCK) is the
rate-limiting enzyme of gluconeogenesis in the liver. PEPCK
gene expression is controlled at the transcriptional level and is
mainly regulated by hormones that are involved in glucose
homeostasis. In this study, we have investigated the role of
glucose on PEPCK gene expression in cultured hepatocytes. We
demonstrate that glucose counteracts the stimulatory effect of
glucocorticoids and cAMP on PEPCK expression. Glucose must
be metabolized through glucokinase to have its inhibitory effect.
The effect of glucose is mainly transcriptional and the region
responsible for glucose inhibition is localized in the first 490 bp of
the promoter.
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1. Introduction
It is now established that glucose stimulates the transcrip-
tion of several genes encoding enzymes belonging to the gly-
colytic and lipogenic pathway in the liver, adipose tissue and
pancreatic L-cells. This is the case for fatty acid synthase
(FAS) and acetyl-CoA carboxylase (ACC), two key enzymes
of the lipogenic pathway, L-pyruvate kinase (L-PK) involved
in hepatic glycolysis and the protein of unknown function
Spot 14 (S14) [1,2]. Studies performed in cultured adipocytes,
cultured hepatocytes and L-cell insulinomas have clearly dem-
onstrated that glucose must be metabolized to activate the
transcription of these genes [3^8]. In the liver, the presence
of glucokinase, which is responsible for glucose phosphoryla-
tion into glucose-6-phosphate (Glu-6-P), is crucial. The iden-
tity of the signal metabolite involved in the glucose e¡ect
remains controversial. We proposed that Glu-6-P could be a
good candidate acting as a signal for glucose responsive genes
[3,7,8]. On the other hand, Doiron et al. favored the hypoth-
esis of the involvement of xylulose-5-phosphate, an intermedi-
ate of the pentose phosphate pathway [9].
Conversely, glucose can inhibit the transcription of various
genes. The most well-known example are the genes encoding
the family of glucose-regulated proteins (GRP). These pro-
teins are localized within the endoplasmic reticulum and the
Golgi apparatus and their expression is induced by a variety
of stresses such as calcium ionophores, reducing agents or
glucose deprivation [10]. Two genes encoding metabolic en-
zymes, the ubiquitous glucose transporter and aspartate ami-
notransferase (one enzyme of the neoglucogenic pathway in
the liver and glyceroneogenic pathway in the adipose tissue),
were described as members of the GRP family because of
their response to glucose and stress treatment [11,12].
Phosphoenolpyruvate carboxykinase (PEPCK; EC 4.1.1.32)
is the rate-limiting enzyme of gluconeogenesis in the liver.
PEPCK gene expression is controlled at the transcriptional
level and is mainly regulated by hormones that are involved
in glucose homeostasis. PEPCK gene transcription is induced
by glucagon, glucocorticoids and inhibited by insulin [13,14].
Concurrently to the well-known inhibition by insulin, several
papers have described the inhibition of PEPCK gene expres-
sion by glucose [15^17].
In H4IIE hepatoma cells which do not express glucokinase,
PEPCK gene expression is insensitive to glucose. Adenovirus-
mediated transfection of this cell line with a glucokinase ex-
pression vector confers glucose sensitivity to PEPCK gene
expression [17]. This suggested that the glucose e¡ect requires
glucose metabolism.
In the present work, we have investigated the e¡ect of glu-
cose on PEPCK gene expression in primary cultures of hep-
atocytes. We demonstrate that glucose inhibits PEPCK ex-
pression only when it can be metabolized. The e¡ect of
glucose is essentially transcriptional and the region responsi-
ble for glucose inhibition is localized in the ¢rst 490 bp of the
promoter.
2. Materials and methods
2.1. Animals
Animal studies were conducted according to the French Guidelines
for the Care and Use of Experimental Animals. Female Wistar rats
(200^300 g body weight) fed ad libitum or 13 day old suckling rats
were used (I¡a-Credo, L’Arbresle, France). They were housed in plas-
tic cages at a constant temperature (22‡C) with light from 07:00 h to
19:00 h for at least 1 week before the experiments.
2.2. Isolation, culture and transfection of hepatocytes
Hepatocytes were isolated by the collagenase method [18]. Cell via-
bility was assessed by the trypan blue exclusion test and was always
higher than 85%. Hepatocytes were seeded at a density of 8U106 cells
(in 100 mm Petri dishes for RNA extraction) or 2U106 cells (in 60
mm Petri dishes for transfection experiments) in medium M199 with
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Earle salts (Life technologies, Paisley, UK) supplemented with 100 U/
ml penicillin, 100 Wg/ml streptomycin, 0.1% (w/v) bovine serum albu-
min, 2% (v/v) Ultroser G (Life Technologies), 100 nM dexamethasone
(Sigma, St. Louis, MO, USA), 1 nM insulin (Actrapid, Novo Nor-
disk, Copenhagen, Denmark), 100 nM triiodothyronine (Sigma).
After a 4 h attachment period, hepatocytes were cultured for 16^18
h in the presence of 5 mM glucose, 100 nM dexamethasone and 100
WM dibutyryl cyclic adenosine monophosphate (Bt2cAMP) in order to
induce PEPCK gene expression. Then, the culture medium was re-
moved and replaced by a fresh medium containing the same concen-
trations of dexamethasone and Bt2cAMP and increasing concentra-
tions of glucose (5^25 mM). Hepatocytes were cultured during 24 h
and harvested for RNA extraction.
For the PEPCK mRNA stability experiments, hepatocytes were
cultured overnight in the presence of 100 nM dexamethasone, 100
WM Bt2cAMP and 5 mM glucose. Then, the medium was replaced
by a fresh similar medium containing 100 WM of the transcription
inhibitor 5,6-dichlorobenzimide riboside (DRB) (Sigma) and 5 or 25
mM glucose.
A XbaI/BglII fragment corresponding to the ¢rst 490 bp of the rat
PEPCK promoter was subcloned into pBLCAT2 (pCK490-CAT)
(American Type Culture Collection, Rockville, MD, USA) and was
used for transfection experiments using N-(1-(2,3-dioleoyloxy) prop-
yl)-N,N,N-trimethylammonium methyl-sulfate (DOTAP) liposomal
transfection reagent (Roche Molecular Biochemicals). Typically,
2U106 hepatocytes in 60 mm dishes were transfected with 5 Wg of
pCK490-CAT and 30 Wl of DOTAP (1 Wg/Wl). After 12^14 h, the
medium containing the DNA/liposome was removed and replaced
by a medium containing or not 100 nM dexamethasone, 100 WM
Bt2cAMP and 5 or 25 mM glucose. Cells were then cultured further
for 48 h and harvested for chloramphenicol acetyltransferase (CAT)
assay as previously described [19]. CAT activity is expressed relative
to the total amount of proteins in cellular extracts.
2.3. Metabolite concentration assay
The intracellular concentration of Glu-6-P in cultured hepatocytes
was measured by a previously described spectrophotometric assay [8].
The medium lactate concentration was assayed according to [20].
2.4. Isolation of total RNA and Northern blot hybridization
Total cellular RNAs were extracted from hepatocytes using the
guanidine thiocyanate method [21] and prepared for Northern blot
hybridization as previously described [22]. Labelling of each probe
was performed by random priming (Rediprime labelling kit, Amer-
sham). Autoradiograms of Northern blots were scanned and quanti-
¢ed using an image processor program. PEPCK cDNA was as pre-
viously described [22]. Each Northern blot was hybridized with a
ribosomal 18S probe in order to verify that equivalent amounts of
total RNA were loaded in each lane.
2.5. Statistical analysis
Results are expressed as means þ S.E.M. Statistical analysis was
performed with Student’s t-test for unpaired data. When quanti¢ed,
PEPCK mRNA concentrations were normalized with respect to the
18S hybridization signal.
3. Results
Glucocorticoids and glucagon acting via cAMP are both
strong activators of PEPCK gene expression in the liver
[23,24]. In a ¢rst series of experiments, we have tested whether
high glucose concentrations could inhibit glucocorticoids and
cAMP-activated PEPCK gene expression in hepatocytes. We
have thus cultured adult rat hepatocytes for 24 h with increas-
ing concentrations of glucose (5^25 mM) in the presence of
dexamethasone, a glucocorticoid analog (Fig. 1A), Bt2cAMP
(Fig. 1B) or the combination of Bt2cAMP and dexamethasone
(Fig. 1C). We observed that whatever the activator of PEPCK
gene expression, glucose is highly e¡ective in counteracting
the stimulatory e¡ect of hormones. The inhibitory e¡ect of
glucose is already visible at a 10 mM concentration and is
increased at higher concentrations (Fig. 1). In all the following
experiments, we have chosen to induce PEPCK gene expres-
sion overnight with dexamethasone and Bt2cAMP in order to
study the mechanism of glucose inhibition.
The inhibitory e¡ect of glucose on PEPCK gene expression
can be mediated by glucose itself or by one of its metabolites.
We have then studied the e¡ect of 3-O-methyl glucose (a
glucose analog which is transported into the cell but not phos-
phorylated) on PEPCK gene expression. 3-O-methyl glucose
at 10 or 25 mM has no inhibitory e¡ect (Fig. 2), suggesting
that glucose needs to be metabolized to achieve its e¡ect. In
addition, this shows that the glucose e¡ect is not linked to an
osmotic mechanism.
It has been clearly demonstrated that in cultured hepato-
cytes, the induction by glucose of glycolytic or lipogenic en-
zymes gene expression requires the presence of a highly e¡ec-
tive glucokinase [6,7]. In the next experiment, we have
compared the e¡ect of glucose on PEPCK gene expression in
fed adult rat hepatocytes and in 13 day old suckling rat hep-
atocytes which do not express glucokinase [25]. We have thus
Fig. 1. E¡ect of increasing concentrations of glucose on glucocorti-
coid- and cAMP-activated PEPCK gene expression in cultured adult
rat hepatocytes. Hepatocytes were cultured for 24 h in the presence
of 5, 10, 15 or 20 mM glucose and 100 nM dexamethasone (dexa)
(A), 100 WM Bt2cAMP (B) or 100 nM dexamethasone plus 100 WM
Bt2cAMP (C). At the end of the culture, total RNAs were extracted
and analyzed for the expression of PEPCK mRNA and 18S rRNA.
A representative Northern blot as well as the quanti¢cation of blots
obtained in three di¡erent experiments are shown. When quanti¢ed,
the concentrations of mRNA are expressed as a ratio to the corre-
sponding 18S signal and as a percentage of the value obtained in
the presence of 5 mM glucose. *, **: Di¡erences statistically signi¢-
cant for respectively P6 0.05 and P6 0.01 when compared to the
value obtained in the presence of 5 mM glucose.
FEBS 22842 28-10-99
F. Cournarie et al./FEBS Letters 460 (1999) 527^532528
cultured hepatocytes in the presence of Bt2cAMP and dexame-
thasone and increasing concentrations of glucose for 24 h.
The capacity of glucokinase to phosphorylate glucose was
assessed by the measurement of Glu-6-P concentrations 1 h
after the addition of the various glucose concentrations and
by the measurement of lactate production in the medium after
24 h of culture. PEPCK mRNA expression was also measured
after 24 h of culture. In suckling rat hepatocytes, Glu-6-P
concentrations remain very low, even in the presence of a
high glucose concentration in the medium (Fig. 3D). Simi-
larly, lactate production in the medium is nearly undetectable,
indicating that glucose metabolism through glucokinase is
minimal in these hepatocytes (Fig. 3D). Interestingly, in suck-
ling rat hepatocytes, glucose is totally ine¡ective in inhibiting
PEPCK gene expression (Fig. 3C). Conversely, in adult rat
hepatocytes, the inhibition of PEPCK gene expression by glu-
cose (Fig. 3A) is concomitant with the presence of an e¡ective
glucokinase activity as shown by the increasing Glu-6-P con-
centrations and increasing lactate production in response to
glucose (Fig. 3B). These data indicate that the presence of a
Fig. 3. Comparison of the e¡ect of glucose on PEPCK gene expression in cultured adult and suckling rat hepatocytes. Determination of Glu-6-
P and lactate concentrations. Adult or 15 day old suckling rat hepatocytes were cultured in the presence of 100 nM dexamethasone, 100 WM
Bt2cAMP and 5, 10, 20 or 25 mM glucose. Cells were harvested after 1 h for the determination of Glu-6-P concentrations or 24 h for total
RNA extraction and lactate determination. Total RNAs were analyzed for the expression of PEPCK mRNA and 18S rRNA in adult (A) or
suckling (C) rat hepatocytes. The Northern blot presented is representative of at least three independent experiments. Glu-6-P and lactate con-
centrations were determined in triplicate for each condition in adult (B) or suckling (D) rat hepatocytes. The results are expressed as percentage
of the values obtained in the presence of 25 mM glucose in adult hepatocytes and as means þ S.E.M. for three independent cultures. Concentra-
tions of Glu-6-P and lactate in the medium were respectively 2.2 þ 0.2 nmol/106 hepatocytes and 310 þ 22 WM/106 hepatocytes in the presence
of 25 mM glucose in adult hepatocytes.
Fig. 2. E¡ect of 3-O-methyl glucose on PEPCK gene expression in
cultured adult rat hepatocytes. Hepatocytes were cultured for 24 h
in the presence of 100 nM dexamethasone, 100 WM Bt2cAMP and
in the presence of 25 mM glucose or 5 mM supplemented or not
with 10 or 25 mM 3-O-methyl glucose. At the end of the culture,
total RNAs were extracted and analyzed for the expression of
PEPCK mRNA and 18S rRNA. A representative Northern blot as
well as the quanti¢cation of blots obtained in three di¡erent experi-
ments are shown. When quanti¢ed, the concentrations of mRNA
are expressed as a ratio to the corresponding 18S signal and as a
percentage of the value obtained in the presence of 5 mM glucose.
Results are presented as the mean þ S.E.M. for three independent
experiments. *, Di¡erence statistically signi¢cant for P6 0.05 when
compared to the value obtained in the presence of 5 mM glucose.
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glucokinase activity is necessary for the inhibition of the
PEPCK gene by glucose in hepatocytes.
We have next investigated the mechanisms by which glucose
inhibits PEPCK gene expression in hepatocytes. At ¢rst, we
have analyzed whether glucose a¡ects the stability of PEPCK
mRNA. Hepatocytes were cultured for 16 h in the presence of
Bt2cAMP and dexamethasone to induce a high expression of
PEPCK. Then, the cells were incubated for 6 h in the presence
of 100 WM DRB, an inhibitor of transcription, and in the
presence of a normal glucose (5 mM) or a high glucose (25
mM) concentration. After blockade of the transcription proc-
ess, the decrease of PEPCK mRNA was similar in the pres-
ence of 5 or 25 mM glucose (Fig. 4), indicating that the
inhibitory e¡ect of glucose on PEPCK gene expression does
not involve a destabilization of PEPCK mRNA.
Finally, we have studied whether glucose acts at a transcrip-
tional level to inhibit PEPCK gene expression. Adult rat hep-
atocytes were transfected by lipofection with the 3490 bp
promoter region of PEPCK linked to a CAT reporter gene.
Then, the cells were cultured for 48 h in the absence or pres-
ence of Bt2cAMP and dexamethasone and 5 or 25 mM glu-
cose. Treatment of the hepatocytes with Bt2cAMP and dex-
amethasone induces strongly the activity of the PEPCK
promoter (Fig. 5). In the presence of 25 mM glucose, a 4-
fold inhibition of PEPCK transcription was observed, indicat-
ing that glucose acts by modi¢cation of the transcription rate
of the PEPCK gene and that the glucose response element is
localized in the ¢rst 490 bp of the promoter.
4. Discussion
The liver plays a major role in glucose homeostasis. When
the plasma glucose concentration is high, the liver synthesizes
glycogen and lipids, the latter being ultimately stored in adi-
pose tissue as triglycerides. When the plasma glucose concen-
tration decreases, the liver produces glucose by the glycoge-
nolytic and the gluconeogenic pathways. Initially, it was
assumed that insulin secreted by the L-cells in response to
carbohydrates regulates at both the post-translational and
transcriptional level the activity of these pathways. More re-
cently, studies performed in cultured cells have pointed out a
role of glucose in the long term regulation of the glycolytic
and lipogenic pathways. Indeed, it is now clear that both
insulin and glucose are required to induce the expression of
genes encoding lipogenic enzymes, ACC and FAS, the lipo-
genic related protein S14 and the glycolytic enzyme L-PK
[1,2]. In addition, for this class of genes, the transcriptional
e¡ect of glucose requires prior metabolism through glucoki-
nase [6,7]. The roles of insulin and glucose are di¡erent. In-
sulin acts by promoting the transcriptional activity of the
transcription factor SREBP-1c. SREBP-1c in turn is su⁄cient
to activate the expression of glucokinase [26] and is necessary
Fig. 4. E¡ect of glucose on PEPCK mRNA stability in cultured
adult rat hepatocytes. Hepatocytes were cultured overnight (18 h) in
the presence of 100 nM dexamethasone, 100 WM Bt2cAMP and
5 mM glucose. Then, cells were incubated with a fresh similar me-
dium containing 5 or 25 mM glucose and 100 WM DRB for 1, 2, 3,
4, 5 or 6 h. At the end of the culture, total RNAs were extracted
and analyzed for the expression of PEPCK mRNA and 18S rRNA.
A representative Northern blot as well as the quanti¢cation of blots
obtained in two di¡erent experiments are shown. When quanti¢ed,
the concentrations of mRNA are expressed as a ratio to the corre-
sponding 18S signal and as a percentage of the value obtained after
the overnight culture with dexamethasone and Bt2cAMP.
Fig. 5. E¡ect of glucose on the hormone-activated PEPCK gene
promoter activity in cultured rat hepatocytes. Hepatocytes were
transfected by lipofection with 5 Wg of pCK490-CAT and 30 Wl DO-
TAP (1 Wg/Wl) as described in Section 2. After 12^14 h, the medium
containing the DNA/liposome was removed and replaced by a me-
dium containing or not 100 nM dexamethasone, 100 WM Bt2cAMP
and 5 or 25 mM glucose. Cells were then cultured further for 48 h
and harvested for the determination of CAT activity. CAT activity
is expressed relative to the total amount of proteins in cellular ex-
tracts. Results are expressed as a percentage of the activity meas-
ured in the presence of 5 mM glucose, dexamethasone and
Bt2cAMP. Results are presented as the mean þ S.E.M. for three in-
dependent experiments. *, Di¡erence statistically signi¢cant for
P6 0.05 when compared to the value obtained in the presence of
5 mM glucose, dexamethasone and Bt2cAMP.
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but not su⁄cient to induce FAS, ACC, L-PK and S14 tran-
scription [27]. A high rate of glucose metabolism then poten-
tiates the e¡ect of SREBP-1c on the promoter of FAS, ACC,
L-PK and S14 by a still unknown mechanism [26].
Concerning PEPCK expression, insulin alone, in the ab-
sence of a high glucose concentration, has an inhibitory e¡ect
[15]. We (present study) and others have shown that the in-
hibitory e¡ect of glucose does not require the immediate pres-
ence of insulin. Taking advantage of a physiological model,
hepatocytes from suckling rats which do not express glucoki-
nase, we demonstrate that in primary hepatocytes, glucose
must be metabolized to have its transcriptional inhibitory ef-
fect. This is in agreement with experiments showing that over-
expression of glucokinase in the livers of diabetic transgenic
mice is accompanied by a decrease in the mRNA encoding
PEPCK and tyrosine aminotransferase [28] and with experi-
ments showing that in H4IIE hepatoma cells which express
only hexokinase I, the inhibitory e¡ect of glucose requires an
adenoviral-mediated overexpression of glucokinase [17]. Since
glucokinase expression is under the strict dependency of in-
sulin, it implies that the glucose e¡ect on PEPCK is indirectly
insulin dependent. This has probably previously been ob-
scured by the fact that in adult rat hepatocytes cultured in
the absence of insulin, a strong activity of glucose phospho-
rylation (see for instance Fig. 3) is still present due to the long
half-life of the glucokinase protein (30 h) [29].
The nature of the glucose signal metabolite is unknown. In
previous experiments in adipose tissue, we have shown that
lactate and pyruvate were unable to mimic the repressive ef-
fect of glucose on PEPCK gene expression [30]. This suggests
that the metabolite belongs to the upper part of the glycolytic
pathway or to the pentose phosphate pathway. In a recent
study performed in rats perfused with xylitol, it has been
suggested that xylulose-5-phosphate might be the metabolite
involved in PEPCK gene inhibition by glucose [31]. Xylulose-
5-phosphate was also proposed by Doiron et al. as the metab-
olite involved in the activation of the L-PK gene [9]. However,
in cultured hepatocytes, a high glucose concentration which
induces FAS, ACC, L-PK and S14 and represses PEPCK
expression does not induce a detectable increase in xylulose-
5-phosphate [8]. Interestingly enough, in HL1C hepatoma cell
lines, the glucose analog 2-deoxyglucose which is not readily
metabolized beyond 2-deoxyglucose-6-phosphate is able to re-
press PEPCK expression, an argument rather in favor of Glu-
6-P as the signal metabolite [17]. We have proposed from
various experiments that for the activating e¡ects of glucose,
Glu-6-P could indeed be the activating factor [3,8]. Further
experiments will be necessary to determine the exact nature of
the glucose metabolite involved in stimulatory and inhibitory
transcriptional e¡ects.
The glucose e¡ect on PEPCK gene expression in hepato-
cytes clearly involves a transcriptional mechanism. First, glu-
cose has no e¡ect on PEPCK mRNA stability (Fig. 4). Sec-
ond, the activity of a 3490 bp fragment of the PEPCK
promoter linked to a reporter gene is strongly inhibited by
glucose. This extends previous observations obtained in
H4IIE hepatoma cell lines showing a repressive e¡ect of glu-
cose on a 32 kb fragment of the PEPCK promoter [17].
Interestingly enough, the 3490 bp region of the promoter
contains liver-speci¢c elements and the elements responsible
for the hormonal regulation of PEPCK expression in the liver.
The cAMP response element is located between 390 and 383
bp on the PEPCK promoter [32] and the glucocorticoid reg-
ulatory unit which contains two glucocorticoid response ele-
ments [33] and an insulin response element is located from
3415 to 3440 bp of the promoter [34]. Glucose is able to
repress both glucorticoid and cAMP-induced PEPCK expres-
sion. This might indicate that the target of glucose is a protein
which integrates these di¡erent signals. Recently, the tran-
scriptional co-activator CREB binding protein (CBP) was
proposed as the coordinator of the factors which control tran-
scription of the PEPCK gene [35]. An attractive hypothesis
would be that CBP is indeed the glucose target.
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